Influence of Ca2+ on the plasma membrane potential and electrogenic uptake of glycine by myeloma cells. Involvement of a Ca2+-activated K+ channel.
The involvement of Ca2+-activated K+ channels in the regulation of the plasma membrane potential and electrogenic uptake of glycine in SP 2/0-AG14 lymphocytes was investigated using the potentiometric indicator 3,3'-diethylthiodicarbocyanine iodide. The resting membrane potential was estimated to be -57 +/- 6 mV (n = 4), a value similar to that of normal lymphocytes. The magnitude of the membrane potential and the electrogenic uptake of glycine were dependent on the extracellular K+ concentration, [K+]o, and were significantly enhanced by exogenous calcium. The apparent Vmax of Na+-dependent glycine uptake was doubled in the presence of calcium, whereas the K0.5 was not affected. Ouabain had no influence on the membrane potential under the conditions employed. Additional criteria used to demonstrate the presence of Ca2+-activated K+ channels included the following: (1) addition of EGTA to calcium supplemented cells elicited a rapid depolarization of the membrane potential that was dependent on [K+]o; (2) the calmodulin antagonist, trifluoperazine, depolarized the membrane potential in a dose-dependent and saturable manner with an IC50 of 9.4 microM; and (3) cells treated with the Ca2+-activated K+ channel antagonist, quinine, demonstrated an elevated membrane potential and depressed electrogenic glycine uptake. Results from the present study provide evidence for Ca2+-activated K+ channels in SP 2/0-AG14 lymphocytes, and that their involvement regulates the plasma membrane potential and thereby the electrogenic uptake of Na+-dependent amino acids.
Pershadsingh
H A
HA
Stubbs
E B
EB
Noteboom
W D
WD
Vorbeck
M L
ML
Martin
A P
AP
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002460:Cell Line; D005998:Glycine / Q000494:pharmacology; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D008214:Lymphocytes; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D010954:Plasmacytoma; D011188:Potassium / Q000378:metabolism*; D011803:Quinine / Q000494:pharmacology; D013816:Thermodynamics; D014268:Trifluoperazine / Q000494:pharmacology
D007473:Ion Channels; D014268:Trifluoperazine; D011803:Quinine; D011188:Potassium; D002118:Calcium; D005998:Glycine